News

The House passed the Maternal Vaccination Act (H.R. 951), an AHA-supported provision from the Black Maternal Health Momnibus Act that would direct the Health and Human Services Secretary to carry out a national campaign emphasizing the importance of maternal vaccinations.

The Centers for Medicare & Medicaid Services will not enforce its COVID-19 vaccine mandate for health care workers while enjoined by district courts in Missouri and Louisiana, the agency confirmed in a memorandum.

The AHA provided comments to the Medicare Payment Advisory Commission on several topics covered during the commission’s November meeting.

The House and Senate passed a continuing resolution to extend funding for federal programs through Feb. 18, avoiding a government shutdown when the current CR expires tonight.

The AHA has developed “What Boards Should Know About Cybersecurity” to assist hospital and health system trustees in asking key questions about their organization’s cybersecurity protocols.

The Department of Health and Human Services launched a central web resource for information on cybersecurity best practices recognized by its 405(d) program.

The Centers for Medicare & Medicaid Services began requiring state Medicaid programs to cover counseling visits at which health care providers talk with families about COVID-19 vaccination for their children

The AHA joined Ascension, Johns Hopkins Medicine and 13 other organizations in launching Telehealth Access for America, a public education campaign to protect access to critical telehealth services. 

An AHA advertorial published in the Wall Street Journal highlights the growing challenges facing the nation’s health care workforce, how America’s hospitals and health systems are working to support them, and the need for policymakers at every level of government to do the same.

The AHA released its latest edition of the COVID-19 Snapshot underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.

President Biden announced his plan for responding to COVID-19 surges and the new omicron variant this winter.

The House will vote later on a continuing resolution to extend funding for federal programs through Feb. 18.

A federal district court in Louisiana late yesterday issued a preliminary injunction placing a temporary hold on enforcement of the Centers for Medicare & Medicaid Services vaccine mandate for health care facilities in all states, except the 10 already covered by the Missouri district court’s preliminary injunction issued on Nov. 29.

The California and San Francisco Departments of Public Health have confirmed the first case of the omicron variant in the United States in an individual in California who was fully vaccinated against COVID-19 and returned Nov. 22 from South Africa, the Centers for Disease Control and Prevention announced today.

Teleflex has recalled a percutaneous thrombolytic device kit due to reports that a component could detach from the device and embolize.

The Food and Drug Administration’s Antimicrobial Drugs Advisory Committee late yesterday voted to recommend an emergency use authorization for Merck’s investigational oral antiviral COVID-19 medicine. The drug, molnupiravir, is meant for the treatment of mild-to-moderate COVID-19 in at-risk adults.

Pfizer yesterday asked the Food and Drug Administration to expand the emergency use authorization for its COVID-19 vaccine booster to include youth aged 16 and 17. 

New HIV infections declined among white gay and bisexual men but remained higher and relatively stable among Black/African American and Hispanic/Latino gay and bisexual men between 2010 and 2019, according to a report released yesterday by the Centers for Disease Control and Prevention.

The Centers for Medicare & Medicaid Services last week released two guidance documents to help states and territories maintain Medicaid and Children’s Health Insurance Program coverage for elig

Twenty-five organizations, including the AHA, today urged Congress to immediately extend the hold on payment cuts and the private payer data reporting period under the Clinical Laboratory Fee Schedule due to the continued COVID-19 public health emergency.